Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) is a Technology Disruptor for Edible Cannabinoids
First mover in plant-to-bloodstream niche Proprietary technology improving bioavailability of orally ingested cannabinoids Two distinct consumer product brands: ViPova™ and Lexaria Energy With the recreational market set for legalization on July 1, 2018, Canada’s cannabis industry is experiencing a high that is catalyzing innovation in the biosciences sector. Pioneering biopharmaceutical companies there and in other developed countries are working to develop a variety of healthful products based on their research into cannabinoids. As a result, investment capital flow to “plant-to-bloodstream” companies is expected to swell just as it has been doing for “seed-to-plant” companies for some time, and innovative British…
